Komori
Techno Medica (6678) · InitiativeAdvanced

Disposal of Treasury Shares as Restricted Stock Compensation

First written in FY2018-Q3. 12 of 15 entries say "Advanced", first in FY2019. Latest entry: 2026-10-07.

15entries
9years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018-Q3 – FY2018AdvancedFY2019 – 2026-10-072018: 220182019: 120192020: 120202021: 120212022: 120222023: 220232024: 220242025: 120252026: 42026
Same theme, other companies
Acquisition and Disposal of Treasury Shares for Stock-Based CompensationA theme 50 companies write about · 0 as a headwind · 50 as a tailwind

24 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Of the 49,830-share decrease in treasury common shares, 15,600 shares resulted from the disposal of treasury shares as restricted stock compensation for the Company's directors, excluding directors who are Audit and Supervisory Committee members, carried out on 25 July 2025, and 34,230 shares resulted from the disposal of treasury shares as restricted stock compensation for the Company's employees carried out on 4 December 2026.」

    Disclosures were made of restricted stock compensation disposals totaling 15,600 director shares and 34,230 employee shares. Operation of the stock compensation program for employees, in addition to officers, is continuing.
  2. FY2025AdvancedAnnual report

    「The 19,800-share decrease in treasury common shares resulted from the disposal of treasury shares as restricted stock compensation for the Company's directors, excluding directors who are Audit and Supervisory Committee members, carried out on 26 July 2024.」

    Disposed of 19,800 shares as restricted stock compensation for directors and added the program's operating results.
  3. FY2024AdvancedAnnual report

    「Of the 138,600-share decrease in treasury common shares, 19,200 shares resulted from the disposal of treasury shares as restricted stock compensation for the Company's directors, excluding directors who are Audit and Supervisory Committee members, carried out on 31 July 2023, and 119,400 shares resulted from the disposal of treasury shares as restricted stock compensation for the Company's employees carried out on 7 December 2023.」

    During the fiscal year, restricted stock compensation was implemented for 19,200 director shares and 119,400 employee shares, for a total of 138,600 shares, and the program's operation was continued and expanded.
  4. FY2024-Q3AdvancedAnnual report

    「On 7 December 2023, the Company disposed of 119,400 treasury shares as restricted stock compensation for its employees.」

    Disposed of 119,400 treasury shares as restricted stock compensation for employees and added operating results for the employee stock compensation program.
  5. FY2023AdvancedAnnual report

    「Of the 56,400-share decrease in treasury common shares, 11,400 shares resulted from the disposal of treasury shares as restricted stock compensation for the Company's directors, excluding directors who are Audit and Supervisory Committee members, carried out on 29 July 2022, and 45,000 shares resulted from the disposal of treasury shares as restricted stock compensation for the Company's employees carried out on 8 December 2022.」

    During the fiscal year, restricted stock compensation was implemented for 11,400 director shares and 45,000 employee shares, for a total of 56,400 shares, and the program's operation was continued and expanded.
  6. FY2023-Q3AdvancedAnnual report

    「Treasury shares decreased by 45,000 shares as a result of the disposal of treasury shares as restricted stock compensation for the Company's employees carried out on 8 December 2022. In addition, treasury shares increased by 1,150 shares from the free acquisition of shares related to restricted stock compensation after 1 October 2022. As a result, the number of treasury shares as of 31 December 2022 was 286,351.」

    Disposed of 45,000 shares to employees as restricted stock compensation on 8 December 2022. In addition to the program's operation for directors and others to date, operating results for the employee program were added.
  7. FY2022AdvancedAnnual report

    「The 4,650-share decrease in treasury common shares resulted from the disposal of treasury shares as restricted stock compensation for the Company's directors, excluding directors who are Audit and Supervisory Committee members, carried out on 30 July 2021.」

    Disposed of 4,650 treasury shares as restricted stock compensation for directors and added the program's operating results.
  8. FY2021AdvancedAnnual report

    「Of the reduction in treasury shares during the fiscal year, 4,650 shares resulted from the disposal of treasury shares as restricted stock compensation for the company’s directors, excluding directors who are Audit and Supervisory Committee members, carried out on 31 July 2020, and 37,700 shares resulted from the disposal of treasury shares as restricted stock compensation for the company’s employees, carried out on 8 December 2020.」

    In addition to 4,650 shares for directors, the company granted restricted stock compensation covering 37,700 shares for employees, expanding the scheme’s eligible recipients and implementation record.
  9. FY2020AdvancedAnnual report

    「The reduction of 4,650 common treasury shares resulted from the disposal of treasury shares as restricted stock compensation for the company’s directors, excluding directors who are Audit and Supervisory Committee members, carried out on 26 July 2019.」

    On 26 July 2019, the company disposed of 4,650 treasury shares to directors, excluding directors who are Audit and Supervisory Committee members, as restricted stock compensation, adding to the record of the scheme’s implementation.
  10. FY2019AdvancedAnnual report

    「The reduction of 5,750 common treasury shares resulted from the disposal of treasury shares as restricted stock compensation for the company’s officers, carried out on 27 July 2018.」

    The full-year disclosure confirms the disposal of 5,750 treasury shares to officers as restricted stock compensation.
  11. FY2018RestatedAnnual report

    「At a meeting of the Board of Directors held on 4 October 2017, the company resolved to dispose of treasury shares as restricted stock compensation and, based on this resolution, disposed of 26,850 treasury shares on 8 December 2017.」

    The full-year report confirms the disposal of 26,850 treasury shares as restricted stock compensation. The scheme, intended to align value with shareholders and enhance corporate value, remains in place.
  12. FY2018-Q3First statedAnnual report

    「At a meeting of the Board of Directors held on 4 October 2017, the company resolved to dispose of treasury shares as restricted stock compensation and, based on this resolution, disposed of 26,850 treasury shares on 8 December 2017.」

    Based on a resolution of the Board of Directors, the company disposed of 26,850 treasury shares as restricted stock compensation. This was the first identified stock compensation measure distinct from the company’s existing treasury share repurchases.
Moved together

"Expansion of Recurring Sales through Related Consumables and Maintenance Services" moved the same way as this thread, in the same document, in 7 of its 15 moves.

766666★123456
  1. ★This thread
  2. 1Expansion of Recurring Sales through Related Consumables and Maintenance Services7×
  3. 2Achieving Stable Growth in Net Sales and a 20% Ordinary Profit Margin on Net Sales6×
  4. 3Expanding Market Share of Blood Collection Tube Preparation Equipment6×
  5. 4Reduced dependence on blood collection tube preparation equipment through the expansion of specimen testing equipment6×
  6. 5Flexible Capital Policy Through Share Repurchases6×
  7. 6Executive Compensation Scheme Focused on Enhancing Corporate Value and Sharing Value with Shareholders6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Techno Medica yet. It last moved in the Share Issuance and Disposal of 2026-10-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Disposal of Treasury Shares as Restricted Stock Compensation | Techno Medica Co.,Ltd. (6678) | Komori